Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Breast Cancer × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 66 Multiple Myeloma 35 Lymphoma, Large B-Cell, Diffuse 35 Lymphoma 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Leukemia 24 Lymphoma, Non-Hodgkin 23 Burkitt Lymphoma 17 Recurrence 16 Lymphoma, Follicular 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Neoplasms, Plasma Cell 15 Lymphoma, Mantle-Cell 15 Lymphoma, B-Cell 13 Leukemia, Myeloid, Acute 12 Hodgkin Disease 11 Lymphoma, Large-Cell, Immunoblastic 10 Neuroblastoma 9 Lymphoma, B-Cell, Marginal Zone 9 Sarcoma 8 Ovarian Neoplasms 8 Lymphoma, T-Cell, Peripheral 8 Triple Negative Breast Neoplasms 7 Myelodysplastic Syndromes 7 Inflammatory Breast Neoplasms 7 Melanoma 6 Immunoblastic Lymphadenopathy 6 Neoplasms 5 Neoplasm Metastasis 5 Lung Neoplasms 5

Interventions

Fulvestrant 5 Letrozole 4 Capecitabine 3 pyrotinib 2 Paclitaxel 2 Goserelin 2 Anastrozole 2 palbociclib 1 olaparib 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 entinostat 1 ceralasertib 1 capivasertib 1 Vinorelbine 1 Trastuzumab 1 Standard of Care 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Injections 1 In Situ Hybridization, Fluorescence 1 Gonadotropin-Releasing Hormone 1 FCN-437c 1 Docetaxel 1 Decitabine 1 Cyclophosphamide 1 Combined Modality Therapy 1 Cisplatin 1 CYH33 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04304352 2023-06-28

VEX

European Institute of Oncology

Phase 2 Unknown

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡